Skip to main content
. 2018 Aug;10(Suppl 23):S2711–S2718. doi: 10.21037/jtd.2018.04.53

Table 3. Efficacy results: responder rates (MCID) at 6-month FU for bilaterally treated patients (all patients).

MCID responder rates at 6-month FU n/N Percent
6MWD responder (≥26 m) 12/20 60.0
SGRQ responder (≥4 points) 20/23 87.0
SGRQ responder (≥8 points) 14/23 60.9
RV responder (≥0.35 L) 19/25 76.0
FEV1 responder (≥10%) 16/28 57.0
Two or more MCIDs responder^ 21/29 72.4

^, at least two MCID responses among 6MWD, SGRQ (4 points), FEV1 and RV; missing values have been counted as non-response. 6MWD, 6-minute walk distance; FEV1, forced expiratory volume in 1 second; FU, follow-up; MCID, minimal clinically important difference; RV, residual volume; SGRQ, St. George Respiratory Questionnaire.